The MELODY Study

The Melody study aims to investigate antibody response to vaccination in patients who are receiving immunosuppression.

Any adult transplant recipient, who has had, or is about to have, their third COVID-19 vaccine can participate by registering themselves at the trial website. They will then be sent a self-test kit to their home address, which takes about 20 minutes to complete and will provide a readout of their antibody status. The results of the test are then uploaded onto the trial website.

To see further information from the study team, please see the document below:

To register to take part in the Study, please click the link below: